EXPRESSING VECTOR (VARIANTS)

genetic engineering, molecular biology. SUBSTANCE: invention proposes expressing vectors including heteropromoter T7, T3, CMV, HIV, LTR or PH and nucleic acid. Nucleic acid encodes protein 6a of human papilloma virus and it can be presented by L2, E1, E2, E4, E5a, E6 and E7. Vector transforms the ye...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KATRIN JU. JANSEN, KATRIN DZH. KHOFMANN
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	genetic engineering, molecular biology. SUBSTANCE: invention proposes expressing vectors including heteropromoter T7, T3, CMV, HIV, LTR or PH and nucleic acid. Nucleic acid encodes protein 6a of human papilloma virus and it can be presented by L2, E1, E2, E4, E5a, E6 and E7. Vector transforms the yeast host-cell. Invention provides to develop prophylactic or therapeutic vaccine against pointed condyloma. EFFECT: enhanced effectiveness of vector. 8 cl, 1 tbl, 9 ex